Condition
Waldenström Macroglobulinemia clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Waldenström Macroglobulinemia clinical trials that are recruiting, at sites in 16 countries (most in United States (2), Canada (2), China (2)). By phase: Phase 1/2 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 16Countries
Newest Waldenström Macroglobulinemia clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Pacritinib for relapsed or refractory Waldenström macroglobulinemia | Phase 2 | Boston, Massachusetts | Recruiting | May 22, 2025 |
| Seeing CXCR4 in lymphoma and leukemia with a new PET tracer | — | Vancouver, British Columbia | Recruiting | Jan 25, 2024 |
| Treatment for B-cell malignancies using BGB-16673 | Phase 1/2 | Bengbu, Anhui and 28 other locations | Recruiting | Mar 24, 2022 |
| Exploring BGB-16673 for treating B-cell malignancies | Phase 1/2 | Birmingham, Alabama and 113 other locations | Recruiting | Aug 16, 2021 |
All recruiting trials (4)
-
Pacritinib for relapsed or refractory Waldenström macroglobulinemia
This trial will test whether the oral drug pacritinib can safely reduce disease and symptoms in adults whose Waldenström macroglobulinemia has returned or did not respond to prior treatment.
-
Seeing CXCR4 in lymphoma and leukemia with a new PET tracer
This study tests a new PET tracer called 18F-BL40 to see if it can image CXCR4-expressing cancers and compares it with the standard 18F-FDG in adults with various blood cancers.
-
Treatment for B-cell malignancies using BGB-16673
This study is testing a new drug called BGB-16673 to see if it can safely help people with different types of B-cell cancers.
-
Exploring BGB-16673 for treating B-cell malignancies
This study is testing a new drug called BGB-16673 to see if it can safely help people with certain types of B-cell cancers, like Marginal Zone Lymphoma and Follicular Lymphoma, who haven't had success with other treatments.
Related topics
Quick answers
How many Waldenström Macroglobulinemia clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 16 countries. The most sites are in United States (2 trials), Canada (2 trials), China (2 trials), Australia (1 trial), Brazil (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.